No Clear Winner in Trial of Tests for Low-Risk Prostate Canc

Two commonly used assays for the severity of prostate cancer performed equally well in a head-to-head trial.

Related Keywords

New York , United States , Memorial Sloan Kettering Cancer Center , Texas , Massachusetts , Boston , Illinois , University Of Houston , Chicago , American , Stephen Spann , Brian Helfand , Anthony Leazzo , Bruce Trock , Andrew Vickers , Johns Hopkins University , Prostate Health Index , American Urological Association , Beckman Coulter , Northshore University Healthsystem , Tilmanj Fertitta Family College Of Medicine , Medscape Medical , New York City , Primary Care Split , Northwestern Medicine Delnor Hospital , Medscaep Medical , Family College , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Prostate , Biopsy , Prostatic , Biomarker , Iological Marker , Cancer , Alignant Neoplasia , Arcinoma , Preventive Screening , Screening , Primary Care ,